Biotechnology
| Fri 16 Oct 2026
Munich, Oct. 15 -- Genmab AS and BioNTech have sought patent for Antibodies Capable of Binding to Ox40 in Combination Therapy. This invention was developed by Garrido Castro Patricia, Breij Esther C W, Diks Annieck, Kemper Kristel, Guelen Lars, De Goeje Pauline Linda, Verzijl Dennis, Fellermeier-kopf Sina, Gorlani Andrea, Sahin ..